Total number of patients with reported drug-induced anaphylaxis 1325
Drug class/name
Anti-infectives, n (%)
544 (41.1)
Beta-lactams, n (%) 402 (30.3)
Quinolones, n (%) 30 (2.3)
Macrolides, n (%) 25 (1.9)
Aminoglycosides, n (%) 24 (1.8)
Glycopeptides, n (%) 19 (1.4)
Anti-protozoals, n (%) 13 (1.0)
Sulphonamides, n (%) 9 (0.7)
Tetracyclines, n (%) 9 (0.7)
Anti-fungals, n (%) 4 (0.3)
Lincosamides, n (%) 3 (0.2)
Anti-virals, n (%) 2 (0.2)
Anti-mycobacterials, n (%) 1 (0.1)
Other anti-infectives, n (%) 3 (0.2)
Musculoskeletal System, n (%)
158 (11.9)
Nervous System, n (%)
157 (11.8)
Anaesthesia, n (%)
155 (11.7)
Immune System and Malignant Diseases, n (%)
99 (7.5)
Gastrointestinal System, n (%)
46 (3.5)
Respiratory System, n (%)
28 (2.1)
Blood and Nutrition, n (%)
25 (1.9)
Skin, n (%)
19 (1.4)
Cardiovascular system, n (%)
19 (1.4)
Eye, n (%)
12 (0.9)
Endocrine System, n (%)
10 (0.8)
Ear, Nose and Throat, n (%)
6 (0.5)
Vaccines, n (%)
4 (0.3)
Genito-urinary system, n (%)
1 (0.1)
Emergency treatment of poisoning, n (%)
1 (0.1)
Unknown drug culprit, n (%)
40 (3.0)